Recombinant varicella vaccine(Beijing lvzhu Biotechnology)

重组水痘疫苗（北京绿竹生物）

Report date: 2023/04/04 15:57:41

Base Information

Drug NameRecombinant varicella vaccine(Beijing lvzhu Biotechnology)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsChickenpox

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBeijing Lvzhu Biological Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Lvzhu Biological Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsChickenpox

Inactive IndicationsN/A

Other Information

ATC CodeN/A